RTC-30

CAS : 1423077-95-5

Ref. 3D-YGC07795

Informations sur le produit

• Nom: RTC-30

Description

RTC-30 is a tricyclic dibenzazepine compound that has been reengineered to have increased potency and selectivity. RTC-30 inhibits the enzyme phosphatase, which is involved in cancer cell proliferation. The pharmacological properties of RTC-30 were assessed using assays for anti-cancer activity in xenografts. In these studies, tumor size was reduced by about 50% at the end of the study, compared to untreated control animals. RTC-30 also inhibited tumor growth in mice with implanted human prostate cancer cells, inhibiting both tumor growth and metastasis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 492.5 g/mol
• Formule: C₂₄H₂₃F₃N₂O₄S
• Degré de pureté: Min. 95%